You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Interleukin-6 (IL6)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Autoantibodies, Interleukin-6 Trial in Frederiksberg (Oral Glucose Tolerance Test, Cycling test)

Recruiting
  • Autoantibodies
  • Interleukin-6
  • Oral Glucose Tolerance Test
  • Cycling test
  • Frederiksberg, Denmark
    Frederiksberg Hospital
May 10, 2023

COVID-19 Trial in Los Angeles (Clazakizumab)

Completed
Has Results
  • COVID-19
  • Los Angeles, California
    Cedars-Sinai Medical Center
Nov 30, 2021

Acute Myeloid Leukemia, Vitamin D Deficiency, ADAMTS13 Trial in Cairo (Cholecalciferol 2800 I.U. ml oral drops)

Completed
  • Acute Myeloid Leukemia
  • +3 more
  • Cholecalciferol 2800 I.U. ml oral drops
  • Cairo, Madinaty, Egypt
    Dina Ashraf Abdelhady
Nov 25, 2021

HIV Trial in Honolulu, New York, Cleveland (Tumor Necrosis Factor soluble receptor-immunoadhesin complex)

Completed
  • HIV Infections
  • Tumor Necrosis Factor soluble receptor-immunoadhesin complex
  • Honolulu, Hawaii
  • +2 more
Oct 28, 2021

Idiopathic Multicentric Castleman's Disease Trial in Beijing, Chengdu (Recombinant Humanized Anti-interleukin-6 Receptor

Recruiting
  • Idiopathic Multicentric Castleman's Disease
  • Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 4mg/kg
  • +2 more
  • Beijing, China
  • +2 more
Apr 26, 2022

Anti-IL6 and Corticosteroid Monotherapy vs Combination in

Recruiting
  • Critical Illness
  • +2 more
  • Interleukin 6 (IL6) Antagonist
  • +2 more
  • Riyadh, Saudi Arabia
    King Faisal Specialist Hospital and Research Center
Mar 4, 2021

Serum Interleukin 6 and 8 in Children With Acute Gastroenteritis

Recruiting
  • Acute Gastroenteritis
  • Acute Diarrhea
  • Evaluation of serum levels of IL-6 and IL-8
  • Sohag, Egypt
    Sohag University Hospital
Jan 15, 2022

Interleukin-6 Antagonists in Critically-ill Covid-19 Patients

Not yet recruiting
  • COVID-19
  • Critical Illness
  • IL6 Antagonist
  • (no location specified)
Jan 29, 2022

IL- 6 Gene Single Nucleotide Polymorphism asIndicator of

Completed
  • Covid19
  • interleuken 6 level measurment
  • Interleukin-6 Gene-174C detection
  • Tanta, El Gharbyia, Egypt
    Bsant Safwat Kasem
May 1, 2022

Anti-IL-6 Receptor Monoclonal Antibodies on Treatment of

Recruiting
  • Rheumatoid Arthritis
  • +3 more
    • Barcelona, Spain
      Hospital de la Santa Creu i Sant Pau
    Apr 25, 2022

    Solid Tumor Trial in Wuhan (HPV-T, Interleukin-2)

    Recruiting
    • Solid Tumor
    • Wuhan, Hubei, China
      Wuhan Union Hospital
    May 31, 2023

    Interleukin-6 Inhibition, Physical Stress, Appetitive Behavior Trial in Copenhagen Ø (Tocilizumab Injectable Product, Saline

    Completed
    • Interleukin-6 Inhibition
    • +2 more
    • Tocilizumab Injectable Product
    • Saline 0.9% 100 ml NaCl 0.9% will be infused over 1 hour
    • Copenhagen Ø, Denmark
      Center For Physical Activity (CFAS)
    Aug 19, 2022

    Adiponectin, IL-6 and hsC-RP in Relation to Carotid Intima-media

    Completed
    • Thalassemia
    • Interleukin-6
    • +3 more
    • Assiut, Egypt
      Assiut University Hospital
    Feb 15, 2021

    Covid19 Trial in Ribeirão Preto, Santo André (Ixekizumab, Aldesleukin, Colchicine)

    Completed
    • Covid19
    • Ixekizumab
    • +3 more
    • Ribeirão Preto, SP, Brazil
    • +1 more
    Jul 26, 2022

    Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19

    Unknown status
    • COVID-19
    • Severe Pneumonia
    • Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]
    • Zagreb, Croatia
      University Hospital for Infectious Diseases "Dr Fran Mihaljevic"
    Nov 10, 2020

    Intracerebral Haemorrhage Trial in Manchester (IL-1Ra Kineret®, IL-1Ra Placebo)

    Completed
    • Intracerebral Haemorrhage
    • IL-1Ra Kineret®
    • IL-1Ra Placebo
    • Manchester, North West, United Kingdom
      Salford Royal NHS Foundation Trust
    Oct 4, 2021

    Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Houston (biological,

    Completed
    • Metastatic Melanoma
    • +3 more
    • Aldesleukin
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 27, 2022

    Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in

    Completed
    Has Results
    • Stage III Cutaneous Melanoma AJCC v7
    • +5 more
    • Aldesleukin
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 17, 2022

    Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston

    Active, not recruiting
    • Metastatic Melanoma
    • +2 more
    • Aldesleukin
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Subarachnoid Hemorrhage Trial in United Kingdom (IL-1Ra, IL-1Ra Placebo)

    Recruiting
    • Subarachnoid Hemorrhage
    • Plymouth, Devon, United Kingdom
    • +11 more
    May 16, 2022

    COVID-19 Trial in Phoenix, Baltimore, New York (Clazakizumab 25 mg, Clazakizumab 12.5 mg, Placebo)

    Recruiting
    • Covid19
    • Baltimore, Maryland
      Johns Hopkins Hospital
    Jun 10, 2021

    Pyrexia Trial in Zürich (Actemra)

    Recruiting
    • Pyrexia
    • Zürich, Switzerland
      University Hospital Zurich, Clinic of Dermatology
    Sep 29, 2021

    COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)

    Active, not recruiting
    • COL6A3 Positive
    • +3 more
    • Aldesleukin
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 22, 2022

    Chronic Kidney Disease, Inflammation, Cardiovascular Risk Trial in Ehime (Ziltivekimab, Placebo (ziltivekimab))

    Completed
    • Chronic Kidney Disease
    • +2 more
    • Ehime, Japan
      Novo Nordisk Investigational Site
    Oct 26, 2021

    NEONATAL SEPSIS Trial in Sohag (INTERLEUKIN 6)

    Not yet recruiting
    • NEONATAL SEPSIS
    • INTERLEUKIN 6
    • Sohag, Egypt
      Sohag University hospitals
    Oct 18, 2022